Lyka Labs Limited (NSE:LYKALABS)
India flag India · Delayed Price · Currency is INR
99.02
+0.12 (0.12%)
Sep 9, 2025, 3:29 PM IST

Revenue by Product

Fiscal year is April - March.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 20202007 - 2019
Period Ending
Mar '24 Mar '23 Mar '22 Mar '21 Mar '20 2007 - 2019
Pharmaceuticals
1.34B
Log In
Log In
Log In
Log In
Upgrade
Pharmaceuticals Growth
27.04%
Log In
Log In
Log In
Log In
Upgrade
Formulations
-
Log In
Log In
Log In
Log In
Upgrade
Formulations Growth
-
Log In
Log In
Log In
Log In
Upgrade
Bulk Drugs
-
Log In
Log In
Log In
Log In
Upgrade
Bulk Drugs Growth
-
Log In
Log In
Log In
Log In
Upgrade
Processing Charges
-
Log In
Log In
Log In
Log In
Upgrade
Processing Charges Growth
-
Log In
Log In
Log In
Log In
Upgrade
Commission
-
Log In
Log In
Log In
Log In
Upgrade
Commission Growth
-
Log In
Log In
Log In
Log In
Upgrade
Royalty
-
Log In
Log In
Log In
Log In
Upgrade
Royalty Growth
-
Log In
Log In
Log In
Log In
Upgrade
Export Incentives
-
Log In
Log In
Log In
Log In
Upgrade
Export Incentives Growth
-
Log In
Log In
Log In
Log In
Upgrade
Other Operating Income
-
Log In
Log In
Log In
Log In
Upgrade
Other Operating Income Growth
-
Log In
Log In
Log In
Log In
Upgrade

Revenue by Geography

Fiscal year is April - March.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 20202007 - 2019
Period Ending
Mar '24 Mar '23 Mar '22 Mar '21 Mar '20 2007 - 2019
India
847.86M
Log In
Log In
Log In
Log In
Upgrade
India Growth
34.21%
Log In
Log In
Log In
Log In
Upgrade
Rest of World
487.79M
Log In
Log In
Log In
Log In
Upgrade
Rest of World Growth
16.26%
Log In
Log In
Log In
Log In
Upgrade